Deflazacort Vs. Prednisolone in Acute-stage ABPA
A Randomized Controlled Trial of Deflazacort Vs. Prednisolone in Acute-stage Allergic Bronchopulmonary Aspergillosis
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
This PHASE2/PHASE3 trial investigates Allergic Bronchopulmonary Aspergillosis and is currently ongoing. Post Graduate Institute of Medical Education and Research, Chandigarh leads this study, which shows 10 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Mar 2025 — Present [monthly]
Active Not Recruiting PHASE2/PHASE3
-
Sep 2024 — Mar 2025 [monthly]
Active Not Recruiting PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Apr 2024 — May 2024 [monthly]
Active Not Recruiting PHASE2_PHASE3
▶ Show 5 earlier versions
-
Dec 2023 — Apr 2024 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
Nov 2022 — Dec 2023 [monthly]
Recruiting PHASE2_PHASE3
-
Mar 2021 — Nov 2022 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Jan 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Post Graduate Institute of Medical Education and Research, Chandigarh
For direct contact, visit the study record on ClinicalTrials.gov .